FDA Creates Medical App Regulation Maze

March 3rd, 2014
Posted by


This post is published on InformationWeek Healthcare, March 3, 2014

 

When the US Food and Drug Administration (FDA) issued its final guidance for medical apps, inventors and investors alike pored through the document, seeking answers on what was to be regulated and what wasn’t. While they indeed found more specific information than has been available from the agency, the guidance also showed the agency’s uncertainty over how the world of medical apps is going to evolve.

 

Read full post on  InformationWeek Healthcare.

Like this content? Don’t miss an update.


About the Author:

My broad career spans across medicine, engineering and business development. At Popper and Company, I develop business strategies and provide guidance to accelerate new product development for medical device companies. Send me an email.